Evidence for the involvement of ERβ and RGS9-2 in 17-β estradiol enhancement of amphetamine-induced place preference behavior

Hormones and Behavior

Volumn 52, Issue 2, 2007, Pages 146-155

  Silverman, Jill L ^a   Koenig, James I ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Estrogen; Nucleus accumbens; Place preference; Psychostimulant; Receptor; RGS9

Indexed keywords

COCAINE; COMPLEMENTARY RNA; DEXAMPHETAMINE; DOPAMINE; ESTRADIOL; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PSYCHOSTIMULANT AGENT; RECEPTOR SUBTYPE; RGS PROTEIN; SULFUR 35; AMPHETAMINE; REGULATOR OF G PROTEIN SIGNALING 9; REGULATOR OF G-PROTEIN SIGNALING 9; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; ESTROGEN ACTIVITY; FEMALE; HISTOLOGY; HORMONE ACTION; IN SITU HYBRIDIZATION; ISOTOPE LABELING; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; DECISION MAKING; DRUG EFFECT; DRUG POTENTIATION; OVARIECTOMY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; DRUG SYNERGISM; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; MODELS, BIOLOGICAL; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RGS PROTEINS;

EID: 34447643226     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2007.03.017     Document Type: Article

References (88)

1. Aragona B.J., Liu Y., Yu Y.J., Curtis J.T., Detwiler J.M., Insel T.R., and Wang Z. Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds. Nat. Neurosci. 9 (2006) 133-139
2. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 64 (1999) 803-812
3. Becker J.B., and Rudick C.N. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol. Biochem. Behav. 64 (1999) 53-57
4. Becker J.B., Beer M.E., and Robinson T.E. Striatal dopamine release stimulated by amphetamine or potassium: influence of ovarian hormones and the light-dark cycle. Brain Res. 311 (1984) 157-160
5. Becker J.B., Molenda H., and Hummer D.L. Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann. N. Y. Acad. Sci. 937 (2001) 172-187
6. Berman D.M., and Gilman A.G. Mammalian RGS proteins: barbarians at the gate. J. Biol. Chem. 273 (1998) 1269-1272
7. Bridges R.S. A quantitative analysis of the roles of dosage, sequence, and duration of estradiol and progesterone exposure in the regulation of maternal behavior in the rat. Endocrinology 114 (1984) 930-940
8. Britton D.R., Curzon P., Mackenzie R.G., Kebabian J.W., Williams J.E., and Kerkman D. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39 (1991) 911-915
9. Burchett S.A., Volk M.L., Bannon M.J., and Granneman J.G. Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine. J. Neurochem. 70 (1998) 2216-2219
10. Carr G.D., and White N.M. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci. 33 (1983) 2551-2557
11. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., and Cosgrove K.P. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 25 (2004) 273-279
12. Chen K., and Kandel D. Relationship between extent of cocaine use and dependence among adolescents and adults in the United States. Drug Alcohol Depend. 68 (2002) 65-85
13. Creutz L.M., and Kritzer M.F. Estrogen receptor-beta immunoreactivity in the midbrain of adult rats: regional, subregional, and cellular localization in the A10, A9, and A8 dopamine cell groups. J. Comp. Neurol. 446 (2002) 288-300
14. Creutz L.M., and Kritzer M.F. Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats. J. Comp. Neurol. 476 (2004) 348-362
15. Daniel J.M. Effects of oestrogen on cognition: what have we learned from basic research?. J. Neuroendocrinol. 18 (2006) 787-795
16. Daniel J.M., and Dohanich G.P. Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J. Neurosci. 21 (2001) 6949-6956
17. Daniel J.M., Fader A.J., Spencer A.L., and Dohanich G.P. Estrogen enhances performance of female rats during acquisition of a radial arm maze. Horm. Behav. 32 (1997) 217-225
18. Daniel J.M., Hulst J.L., and Berbling J.L. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 147 (2006) 607-614
19. Daniel J.M., Sulzer J.K., and Hulst J.L. Estrogen increases the sensitivity of ovariectomized rats to the disruptive effects produced by antagonism of D2 but not D1 dopamine receptors during performance of a response learning task. Horm. Behav. 49 (2006) 38-44
20. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., and Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 Suppl. 1 (2004) 227-241
21. Di Paolo T., Bedard P.J., Dupont A., Poyet P., and Labrie F. Effects of estradiol on intact and denervated striatal dopamine receptors and on dopamine levels: a biochemical and behavioral study. Can. J. Physiol. Pharmacol. 60 (1982) 350-357
22. Di Paolo T., Rouillard C., and Bedard P. 17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur. J. Pharmacol. 117 (1985) 197-203
23. Dohlman H.G., and Thorner J. RGS proteins and signaling by heterotrimeric G proteins. J. Biol. Chem. 272 (1997) 3871-3874
24. Dreher J.C., Schmidt P.J., Kohn P., Furman D., Rubinow D., and Berman K.F. Menstrual cycle phase modulates reward-related neural function in women. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 2465-2470
25. Febo M., Gonzalez-Rodriguez L.A., Capo-Ramos D.E., Gonzalez-Segarra N.Y., and Segarra A.C. Estrogen-dependent alterations in D2/D3-induced G protein activation in cocaine-sensitized female rats. J. Neurochem. 86 (2003) 405-412
26. Frye C.A., and Rhodes M.E. Administration of estrogen to ovariectomized rats promotes conditioned place preference and produces moderate levels of estrogen in the nucleus accumbens. Brain Res. 1067 (2006) 209-215
27. Gold S.J., Ni Y.G., Dohlman H.G., and Nestler E.J. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci. 17 (1997) 8024-8037
28. Gold S.J., Han M.H., Herman A.E., Ni Y.G., Pudiak C.M., Aghajanian G.K., Liu R.J., Potts B.W., Mumby S.M., and Nestler E.J. Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur. J. Neurosci. 17 (2003) 971-980
29. Gonzalez-Flores O., Camacho F.J., Dominguez-Salazar E., Ramirez-Orduna J.M., Beyer C., and Paredes R.G. Progestins and place preference conditioning after paced mating. Horm. Behav. 46 (2004) 151-157
30. Hiemke C., Schmid A., Buttner D., and Ghraf R. Improved model for the induction of proestrus-like gonadotropin surges in long-term ovariectomized rats. J. Steroid Biochem. 28 (1987) 357-359
31. Hruska R.E. Elevation of striatal dopamine receptors by estrogen: dose and time studies. J. Neurochem. 47 (1986) 1908-1915
32. Hu M., and Becker J.B. Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J. Neurosci. 23 (2003) 693-699
33. Hu M., Crombag H.S., Robinson T.E., and Becker J.B. Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology 29 (2004) 81-85
34. Ikeda M., Hirokawa M., Satani N., Kinoshita T., Watanabe Y., Inoue H., Tone S., Ishikawa T., and Minatogawa Y. Molecular cloning and characterization of a steroid receptor-binding regulator of G-protein signaling protein cDNA. Gene 273 (2001) 207-214
35. Ikemoto S., Qin M., and Liu Z.H. The functional divide for primary reinforcement of d-amphetamine lies between the medial and lateral ventral striatum: is the division of the accumbens core, shell, and olfactory tubercle valid?. J. Neurosci. 25 (2005) 5061-5065
36. Jackson L.R., Robinson T.E., and Becker J.B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 31 (2006) 129-138
37. Kalivas P.W., and McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168 (2003) 44-56
38. Kebabian J.W., and Calne D.B. Multiple receptors for dopamine. Nature 277 (1979) 93-96
39. Koob G.F. Hedonic valence, dopamine and motivation. Mol. Psychiatry 1 (1996) 186-189
40. Kovoor A., Seyffarth P., Ebert J., Barghshoon S., Chen C.K., Schwarz S., Axelrod J.D., Cheyette B.N., Simon M.I., Lester H.A., and Schwarz J. D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J. Neurosci. 25 (2005) 2157-2165
41. Kritzer M.F. Long-term gonadectomy affects the density of tyrosine hydroxylase- but not dopamine-beta-hydroxylase-, choline acetyltransferase- or serotonin-immunoreactive axons in the medial prefrontal cortices of adult male rats. Cereb. Cortex 13 (2003) 282-296
42. Lammers C.H., D'Souza U., Qin Z.H., Lee S.H., Yajima S., and Mouradian M.M. Regulation of striatal dopamine receptors by estrogen. Synapse 34 (1999) 222-227
43. Le Saux M., and Di Paolo T. Chronic estrogenic drug treatment increases preproenkephalin mRNA levels in the rat striatum and nucleus accumbens. Psychoneuroendocrinology 30 (2005) 251-260
44. Le Saux M., Morissette M., and Di Paolo T. ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens. Neuropharmacology 50 (2006) 451-457
45. Li M., and Fleming A.S. The nucleus accumbens shell is critical for normal expression of pup-retrieval in postpartum female rats. Behav. Brain Res. 145 (2003) 99-111
46. Lund T.D., Rovis T., Chung W.C., and Handa R.J. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 146 (2005) 797-807
47. Lynch W.J., and Carroll M.E. Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology (Berl) 144 (1999) 77-82
48. Lynch W.J., and Taylor J.R. Decreased motivation following cocaine self-administration under extended access conditions: effects of sex and ovarian hormones. Neuropsychopharmacology 30 (2005) 927-935
49. Lynch W.J., Roth M.E., and Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology (Berl) 164 (2002) 121-137
50. Maldonado-Irizarry C.S., and Kelley A.E. Excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat. Brain Res. Bull. 38 (1995) 551-559
51. McFarland K., and Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 21 (2001) 8655-8663
52. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 Suppl. 1 (2004) 24-32
53. Nestler E.J., and Carlezon Jr. W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry (2006)
54. Nordstrom A.L., Olsson H., and Halldin C. A PET study of D2 dopamine receptor density at different phases of the menstrual cycle. Psychiatry Res. 83 (1998) 1-6
55. Ogawa S., Eng V., Taylor J., Lubahn D.B., Korach K.S., and Pfaff D.W. Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology 139 (1998) 5070-5081
56. Ogawa S., Chan J., Chester A.E., Gustafsson J.A., Korach K.S., and Pfaff D.W. Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12887-12892
57. Peris J., Decambre N., Coleman-Hardee M.L., and Simpkins J.W. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release. Brain Res. 566 (1991) 255-264
58. Pettit H.O., and Justice Jr. J.B. Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol. Biochem. Behav. 34 (1989) 899-904
59. Pfaff D., and Keiner M. Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J. Comp. Neurol. 151 (1973) 121-158
60. Pontieri F.E., Tanda G., and Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 12304-12308
61. Quinones-Jenab V. Why are women from Venus and men from Mars when they abuse cocaine?. Brain Res. 1126 (2006) 200-203
62. Quinones-Jenab V., Krey L.C., Schlussman S.D., Ho A., and Kreek M.J. Chronic 'binge' pattern cocaine alters the neuroendocrine profile of pregnant rats. Neurosci. Lett. 282 (2000) 120-122
63. Rahman Z., Gold S.J., Potenza M.N., Cowan C.W., Ni Y.G., He W., Wensel T.G., and Nestler E.J. Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J. Neurosci. 19 (1999) 2016-2026
64. Rahman Z., Schwarz J., Gold S.J., Zachariou V., Wein M.N., Choi K.H., Kovoor A., Chen C.K., DiLeone R.J., Schwarz S.C., Selley D.E., Sim-Selley L.J., Barrot M., Luedtke R.R., Self D., Neve R.L., Lester H.A., Simon M.I., and Nestler E.J. RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38 (2003) 941-952
65. Robinson T.E. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berl) 84 (1984) 466-475
66. Roesch D.M. Effects of selective estrogen receptor agonists on food intake and body weight gain in rats. Physiol. Behav. 87 (2006) 39-44
67. Russell J.M., Murphree E., Janik J., and Callahan P. Effect of steroids and nitric oxide on pituitary hormone release in ovariectomized, peripubertal rats. Reproduction 129 (2005) 497-504
68. Russo S.J., Jenab S., Fabian S.J., Festa E.D., Kemen L.M., and Quinones-Jenab V. Sex differences in the conditioned rewarding effects of cocaine. Brain Res. 970 (2003) 214-220
69. Russo S.J., Festa E.D., Fabian S.J., Gazi F.M., Kraish M., Jenab S., and Quinones-Jenab V. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 120 (2003) 523-533
70. Self D.W., Barnhart W.J., Lehman D.A., and Nestler E.J. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271 (1996) 1586-1589
71. Sell S.L., Scalzitti J.M., Thomas M.L., and Cunningham K.A. Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats. J. Pharmacol. Exp. Ther. 293 (2000) 879-886
72. Sellings L.H., and Clarke P.B. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J. Neurosci. 23 (2003) 6295-6303
73. Sharifi J.L., Brady D.L., and Koenig J.I. Estrogen modulates RGS9 expression in the nucleus accumbens. Neuroreport 15 (2004) 2433-2436
74. Shughrue P.J., and Merchenthaler I. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J. Comp. Neurol. 436 (2001) 64-81
75. Shughrue P., Scrimo P., Lane M., Askew R., and Merchenthaler I. The distribution of estrogen receptor-beta mRNA in forebrain regions of the estrogen receptor-alpha knockout mouse. Endocrinology 138 (1997) 5649-5652
76. Swanson L.W. Brain Maps: Structure of the Rat Brain. 3rd edition (2004), Academic Press, London
77. Thompson T.L., and Certain M.E. Estrogen mediated inhibition of dopamine transport in the striatum: regulation by G alpha i/o. Eur. J. Pharmacol. 511 (2005) 121-126
78. Thompson T.L., and Moss R.L. Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects. J. Neurochem. 62 (1994) 1750-1756
79. Thompson T.L., Bridges S.R., and Weirs W.J. Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment. Brain Res. Bull. 54 (2001) 631-638
80. van Haaren F., and Meyer M.E. Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol. Biochem. Behav. 39 (1991) 923-927
81. Walf A.A., and Frye C.A. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 30 (2005) 1598-1609
82. Walf A.A., Rhodes M.E., and Frye C.A. Ovarian steroids enhance object recognition in naturally cycling and ovariectomized, hormone-primed rats. Neurobiol. Learn. Mem. 86 (2006) 35-46
83. Walf A.A., Rhodes M.E., Meade J.R., Harney J.P., and Frye C.A. Estradiol-induced conditioned place preference may require actions at estrogen receptors in the nucleus accumbens. Neuropsychopharmacology 32 (2007) 522-530
84. White T.L., Justice A.J., and de Wit H. Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol. Biochem. Behav. 73 (2002) 729-741
85. Wise R.A., Murray A., and Bozarth M.A. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology (Berl) 100 (1990) 355-360
86. Woolley C.S., Weiland N.G., McEwen B.S., and Schwartzkroin P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 17 5 (1997) 1848-1859
87. Woolley C.S., Weiland N.G., McEwen B.S., and Schwartzkroin P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 17 (1997) 1848-1859
88. Xiao L., and Becker J.B. Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release. Synapse 29 (1998) 379-391